Condition
Locally Advanced Esophageal Squamous Cell Carcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 7 Locally Advanced Esophageal Squamous Cell Carcinoma clinical trials that are recruiting, in China. By phase: Phase 2 (5), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 1Country
Newest Locally Advanced Esophageal Squamous Cell Carcinoma clinical trials
All recruiting trials (7)
-
Interferon-gamma plus camrelizumab with chemotherapy before surgery for locally advanced esophageal squamous cell carcinoma
This trial tests whether giving interferon-gamma with camrelizumab and chemotherapy before surgery helps patients with locally advanced esophageal squamous cell carcinoma.
-
Tislelizumab plus chemotherapy to convert unresectable locally advanced esophageal squamous cell carcinoma to surgery
This study will try whether adding the immune drug tislelizumab to chemotherapy can shrink tumors so people with initially unresectable locally advanced esophageal squamous cell carcinoma can become eligible for surgery.
-
Optimizing treatment for advanced esophageal cancer
This study is testing a new treatment plan that combines chemotherapy, immunotherapy, and radiotherapy to see if it can help people with advanced esophageal cancer feel better and improve their chances of recovery.
-
Combining Toripalimab with Chemoradiotherapy for Esophageal Cancer
This study is testing if adding a new drug called Toripalimab to standard chemotherapy and radiation can help people with locally advanced esophageal cancer respond better to treatment before surgery.
-
Cadonilimab with paclitaxel micelles and cisplatin before surgery for locally advanced esophageal squamous cancer
This trial will test whether giving cadonilimab together with paclitaxel polymeric micelles and cisplatin before surgery helps people with locally advanced esophageal squamous cell carcinoma.
-
Immunotherapy with radiotherapy and nutrition support for advanced esophageal cancer in patients who can’t tolerate standard chemoradiation
This trial tests whether adding a PD-1 inhibitor (sintilimab) to radiotherapy plus specialized nutrition helps patients with locally advanced esophageal squamous cell carcinoma who can’t tolerate standard chemoradiation.
-
Using Toripalimab after Chemoradiotherapy for Elderly Esophageal Cancer
This study is testing if the drug toripalimab can help older patients with advanced esophageal cancer feel better and lower their chances of the cancer coming back after they’ve had chemoradiotherapy.
Related topics
Quick answers
How many Locally Advanced Esophageal Squamous Cell Carcinoma clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 5, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.